About Biograil
Biograil is a pre-clinical stage Danish pharmaceutical company founded in 2019 and based in Roskilde. Its BIONDD platform is a mechanical device inside a standard swallowable capsule that delivers drugs into the stomach wall, aiming to replace injections for biologics. The company works with partners such as CSL and is backed by Verve Ventures, Megatrend Invest, HTGF and Evonik Venture Capital. In November 2026 it raised EUR 20 million to prepare clinical trials.
Founders
Karsten Lindhardt
CEO & Founder
Former Chief Scientific Officer of Egalet.
Nikolaj Skak
CSO & Founder

- Biotech & Life Sciences
- Roskilde, Denmark
- 2019
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| Series B | €20.0m | — |



